Email this article CURRENT ISSUES IN THE TREATMENT OF ACUTE RESPIRATORY VIRUS INFECTIONS
- Authors: Mustafaev D.M.1
-
Affiliations:
- State Institution of Health of Moscow Region M.F. Vladimirsky Moscow Regional Research Clinical Institute
- Issue: Vol 7, No 3-4 (2013)
- Pages: 109-117
- Section: PHARMACOTHERAPY
- Published: 14.07.2014
- URL: https://klinitsist.abvpress.ru/Klin/article/view/21
- DOI: https://doi.org/10.17650/1818-8338-2013-3-4-109-117
- ID: 21
Cite item
Full Text
Abstract
The article deals with the etiology, diagnosis and treatment of acute respiratory infections (ARI). Contemporary possibilities and tactics ethiotropy treatment of antiviral therapy. Given that to date the treatment of ARI is a significant problem associated with both unjustifiably
widespread use of antibiotics , as well as a huge market saturation of pharmaceutical products for the symptomatic treatment of ARI, the
author gives a critical analysis of drugs used for the pharmacotherapy of viral respiratory infections. The results of the literature review and evaluation of the therapeutic efficacy of immune-tolerance of domestic drug Ergoferon in adults and children who become ill with influenza and ARI. Displaying Ergoferon stimulatory effect on production of endogenous IFN-α and IFN-γ, as well as normalization of subpopulations of T-lymphocytes and histamine levels, thereby reducing the time of clinical signs of disease, prevent the onset and exacerbation of typical complications of chronic somatic diseases.
About the authors
D. M. Mustafaev
State Institution of Health of Moscow Region M.F. Vladimirsky Moscow Regional Research Clinical Institute
Author for correspondence.
Email: mjavanshir@mail.ru
Russian Federation
References
Supplementary files
